AdaptHealth

CMS Pressure Will Crimp Home Healthcare Yet Tech Aids Recovery

AnalystLowTarget

Not Invested

Community Contributor

Published

02 Sep 25

AnalystLowTarget's Fair Value

US$10.50

14.8% undervalued

02 Sep

US$8.95

-18.6%

-0.2%

-18.6%

-0.2%

You can edit this narrative until Sep 2 10:19 PM. Then, changes will post as Updates.

Author's Valuation

US$10.514.8% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$10.5

14.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.86%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.25%

Calculation

US$168.08m

Earnings '28

10.52x

PE Ratio '28

US$1.77b

Market Cap '28

US$1.77b

Market Cap '28

134.62m

No. shares '28

US$13.13

Share Price '28

US$13.13 Share Price '28

Discounted to 2025 @ 7.91% p.a.

US$10.45

Fair Value '25